LAMEA 真實世界證據解決方案市場規模、份額和行業趨勢分析報告：按組成部分、治療領域、最終用戶、應用、國家、增長預測，2022-2028 年

拉丁美洲、中東和非洲真實世界證據解決方案市場在預測期內（2022 年至 2028 年）的複合年增長率將達到 10.7%。

當地醫療保健行業的未來由幾個不斷變化的趨勢因素決定。 不斷上升的醫療保健成本、不斷變化的人口和疾病人口結構、對醫療保健質量的關注、醫療保健數據的數字化、對本地臨床和經濟數據不斷增長的需求、醫療保健行業全球趨勢的整體影響等都是因素。 然而，要使該地區充分受益於 RWE，必須克服障礙，例如接受 RWE 為醫療保健決策和利益相關者之間建立信任帶來的價值。 其他好處包括建立用於生成 RWE 的數據庫的有效性和可靠性、投資本地數據生成以及提高技術能力。 這些因素將進一步促進開展高質量的 RWE 研究，同時保護患者的隱私。 這種不斷增長的醫療保健行業將推動 LAMEA 對真實世界證據解決方案市場的需求。

2021 年按國家/地區劃分的 LAMEA 真實世界證據解決方案市場將由巴西市場主導，並將在 2028 年之前保持主導市場；實現市場價值。 阿根廷市場在此期間 (2022-2028) 的複合年增長率為 11.3%。 此外，阿聯酋市場預計在 2022-2028 年期間的複合年增長率為 10.4%。

市場根據組件細分為服務和數據集。 根據治療領域，市場分為腫瘤學、心髒病學、神經病學、糖尿病、呼吸病學等。 基於最終用戶，市場分為醫療保健公司、醫療保健支付者、醫療保健提供者等。 按應用劃分，市場分為藥物開發和批准、醫療器械開發和批准、報銷、補償和監管決策，以及上市後安全和不良事件監測。 按國家/地區劃分，市場分為巴西、阿根廷、阿聯酋、沙特阿拉伯、南非、尼日利亞和拉美其他地區。

內容

第一章市場範圍與研究方法

• 市場定義
• 目的
• 市場規模
• 細分
  • LAMEA 真實世界證據解決方案市場，按組件分類
  • LAMEA 真實世界證據解決方案市場，按治療領域劃分
  • LAMEA 真實世界證據解決方案市場，按最終用戶分類
  • LAMEA 真實世界證據解決方案市場：按應用分類
  • LAMEA 真實世界證據解決方案市場：按國家/地區分類
• 調查方法

第 2 章市場概述

• 介紹
  • 概覽
    • 市場情景和構成
• 影響市場的主要因素
  • 市場驅動力
  • 市場製約因素

第 3 章在現實世界證據解決方案市場部署的策略

第 4 章 LAMEA 真實世界證據解決方案市場：按組件分類

• LAMEA 服務市場：按國家/地區分類
• LAMEA 數據集市場：按國家/地區分類

第 5 章 LAMEA 真實世界證據解決方案市場：按治療領域分類

• LAMEA 腫瘤學市場：按國家/地區分類
• LAMEA 心髒病學市場趨勢（按國家/地區劃分）
• LAMEA 神經病學市場：按國家/地區分類
• LAMEA 糖尿病市場：按國家/地區分類
• 按國家/地區劃分的 LAMEA 呼吸內科市場
• LAMEA 其他國家/地區市場

第 6 章 LAMEA 真實世界證據解決方案市場的最終用戶

• LAMEA 醫療保健企業市場：按國家/地區分類
• LAMEA 醫療保健付款人市場：按國家/地區分類
• 按國家/地區劃分的 LAMEA 醫療保健提供商市場
• LAMEA 其他國家/地區市場

第 7 章：按應用分類的 LAMEA 真實世界證據解決方案市場

• LAMEA 藥物開發和批准市場的趨勢（按國家/地區劃分）
• LAMEA 醫療器械開發和審批市場：按國家/地區分類
• LAMEA 報銷/補償和監管決策市場：按國家/地區分類
• LAMEA 上市後安全和不良事件監測市場：按國家/地區分類

第 8 章 LAMEA 真實世界證據解決方案市場（按國家/地區劃分）

• 巴西真實世界證據解決方案市場
  • 巴西真實世界證據解決方案市場：按組成部分
  • 巴西真實世界證據解決方案市場：按治療領域分類
  • 巴西真實世界證據解決方案市場（按最終用戶）
  • 巴西真實世界證據解決方案市場：按應用分類
• 阿根廷真實世界證據解決方案市場
  • 阿根廷真實世界證據解決方案市場：按組成部分
  • 阿根廷真實世界證據解決方案市場（按治療領域）
  • 阿根廷真實世界證據解決方案市場（按最終用戶分類）
  • 阿根廷真實世界證據解決方案市場：按應用分類
• 阿聯酋真實世界證據解決方案市場
  • 阿聯酋真實世界證據解決方案市場：按組件分類
  • 阿聯酋真實世界證據解決方案的治療領域市場
  • 阿聯酋真實世界證據解決方案市場（按最終用戶）
  • 阿聯酋真實世界證據解決方案市場（按應用）
• 沙特阿拉伯的真實世界證據解決方案市場
  • 沙特阿拉伯真實世界證據解決方案市場：按組成部分
  • 沙特阿拉伯真實世界證據解決方案市場（按治療領域）
  • 沙特阿拉伯真實世界證據解決方案市場：按最終用戶分類
  • 沙特阿拉伯真實世界證據解決方案市場：按應用分類
• 南非真實世界證據解決方案市場
  • 南非真實世界證據解決方案市場：按組成部分
  • 南非真實世界證據解決方案市場：按治療領域分類
  • 南非真實世界證據解決方案市場（按最終用戶）
  • 南非真實世界證據解決方案市場：按應用分類
• 尼日利亞的真實世界證據解決方案市場
  • 尼日利亞真實世界證據解決方案市場：按組成部分
  • 尼日利亞真實世界證據解決方案市場：按治療領域分類
  • 尼日利亞真實世界證據解決方案市場：按最終用戶分類
  • 尼日利亞真實世界證據解決方案市場（按應用）
• 世界其他地區的真實世界證據解決方案市場 (LAMEA)
  • 世界其他地區：按組件劃分的真實世界證據解決方案市場
  • LAMEA 國家/地區的其他真實世界證據解決方案市場：按治療領域分類
  • LAMEA 其他地區：最終用戶的真實世界證據解決方案市場
  • LAMEA 世界其他地區真實世界證據解決方案市場：按應用分類

第九章：公司簡介

• IBM Corporation
• Oracle Corporation
• PPD, Inc.（Thermo Fisher Scientific, Inc.）
• UnitedHealth Group, Inc.（Optum, Inc.）
• Syneos Health, Inc.
• IQVIA Holdings, Inc.
• Medpace Holdings, Inc.
• ICON plc
• PerkinElmer, Inc.
• Parexel International Corporation（Phoenix Parentco, Inc.）

The Latin America, Middle East and Africa Real World Evidence Solutions Market would witness market growth of 10.7% CAGR during the forecast period (2022-2028).

RWE is being utilized by pharma in more novel ways. RWE is used by some for clinical trial planning and recruiting. In contrast, others use it for post-market safety and unfavorable event monitoring or financial analyses relating to payer reimbursement. Some companies are incorporating ways to continuous learning into their lifecycle of product development.

Additionally, digital health innovation has considerably improved wearable technology's capabilities, which has led to a rise in the usage of recent technological advancements in clinical studies. More than 1,000 completed or continuing clinical research involving wearables were listed in the ClinicalTrials.gov database, mainly in oncology, neuroscience, and respiratory and metabolic illnesses. These developments are fostering the market for real-world evidence solutions.

The regional healthcare industry's future is shaped by several elements, which is why the trend is altering. Rising healthcare costs, shifting population & disease demographics, increased healthcare quality emphasis, medical data digitization, rising demand for regional clinical & economic data, and a general influence of worldwide trends in the medical industry are some of the other factors. However, for the region to fully benefit from RWE in treatment decisions, it must overcome some obstacles, such as accepting the worth that RWE puts to healthcare decisions, and fostering trust among stakeholders. Additionally, establishment of the validity & reliability of the databases utilized to generate RWE, investment in the generation of local data, and improving technical capabilities would benefit the market. These factors would further proliferate the undertaking of high-quality RWE research while protecting patient confidentiality. These rising healthcare sector would drive the demand of Real World Evidence Solutions Market in LAMEA.

The Brazil market dominated the LAMEA Real World Evidence Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $933 million by 2028.The Argentina market is exhibiting a CAGR of 11.3% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 10.4% during (2022 - 2028).

Based on Component, the market is segmented into Services and Data Set. Based on Therapeutic Area, the market is segmented into Oncology, Cardiology, Neurology, Diabetes, Respiratory and Others. Based on End-user, the market is segmented into Healthcare Companies, Healthcare Payers, Healthcare Providers and Others. Based on Application, the market is segmented into Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making and Post Market Safety & Adverse Events Monitoring. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBM Corporation, Oracle Corporation, Medpace Holdings, Inc., IQVIA Holdings, Inc., ICON plc, PerkinElmer, Inc., Parexel International Corporation (Phoenix Parentco, Inc.), PPD, Inc. (Thermo Fisher Scientific, Inc.), UnitedHealth Group, Inc. (Optum, Inc.), and Syneos Health, Inc.

Scope of the Study

Market Segments covered in the Report:

By Component

• Services
• Data Set

By Therapeutic Area

• Oncology
• Cardiology
• Neurology
• Diabetes
• Respiratory
• Others

By End-user

• Healthcare Companies
• Healthcare Payers
• Healthcare Providers
• Others

By Application

• Drug Development & Approvals
• Medical Device Development & Approvals
• Reimbursement/Coverage & Regulatory Decision Making
• Post Market Safety & Adverse Events Monitoring

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled

• IBM Corporation
• Oracle Corporation
• Medpace Holdings, Inc.
• IQVIA Holdings, Inc.
• ICON plc
• PerkinElmer, Inc.
• Parexel International Corporation (Phoenix Parentco, Inc.)
• PPD, Inc. (Thermo Fisher Scientific, Inc.)
• UnitedHealth Group, Inc. (Optum, Inc.)
• Syneos Health, Inc.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 LAMEA Real World Evidence Solutions Market, by Component
  • 1.4.2 LAMEA Real World Evidence Solutions Market, by Therapeutic Area
  • 1.4.3 LAMEA Real World Evidence Solutions Market, by End-user
  • 1.4.4 LAMEA Real World Evidence Solutions Market, by Application
  • 1.4.5 LAMEA Real World Evidence Solutions Market, by Country
• 1.5 Methodology for the research

Chapter 2. Market Overview

• 2.1 Introduction
  • 2.1.1 Overview
    • 2.1.1.1 Market Scenario and Composition
• 2.2 Key Factors Impacting the Market
  • 2.2.1 Market Drivers
  • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Real World Evidence Solutions Market

Chapter 4. LAMEA Real World Evidence Solutions Market by Component

• 4.1 LAMEA Services Market by Country
• 4.2 LAMEA Data Set Market by Country

Chapter 5. LAMEA Real World Evidence Solutions Market by Therapeutic Area

• 5.1 LAMEA Oncology Market by Country
• 5.2 LAMEA Cardiology Market by Country
• 5.3 LAMEA Neurology Market by Country
• 5.4 LAMEA Diabetes Market by Country
• 5.5 LAMEA Respiratory Market by Country
• 5.6 LAMEA Others Market by Country

Chapter 6. LAMEA Real World Evidence Solutions Market by End-user

• 6.1 LAMEA Healthcare Companies Market by Country
• 6.2 LAMEA Healthcare Payers Market by Country
• 6.3 LAMEA Healthcare Providers Market by Country
• 6.4 LAMEA Others Market by Country

Chapter 7. LAMEA Real World Evidence Solutions Market by Application

• 7.1 LAMEA Drug Development & Approvals Market by Country
• 7.2 LAMEA Medical Device Development & Approvals Market by Country
• 7.3 LAMEA Reimbursement/Coverage & Regulatory Decision Making Market by Country
• 7.4 LAMEA Post Market Safety & Adverse Events Monitoring Market by Country

Chapter 8. LAMEA Real World Evidence Solutions Market by Country

• 8.1 Brazil Real World Evidence Solutions Market
  • 8.1.1 Brazil Real World Evidence Solutions Market by Component
  • 8.1.2 Brazil Real World Evidence Solutions Market by Therapeutic Area
  • 8.1.3 Brazil Real World Evidence Solutions Market by End-user
  • 8.1.4 Brazil Real World Evidence Solutions Market by Application
• 8.2 Argentina Real World Evidence Solutions Market
  • 8.2.1 Argentina Real World Evidence Solutions Market by Component
  • 8.2.2 Argentina Real World Evidence Solutions Market by Therapeutic Area
  • 8.2.3 Argentina Real World Evidence Solutions Market by End-user
  • 8.2.4 Argentina Real World Evidence Solutions Market by Application
• 8.3 UAE Real World Evidence Solutions Market
  • 8.3.1 UAE Real World Evidence Solutions Market by Component
  • 8.3.2 UAE Real World Evidence Solutions Market by Therapeutic Area
  • 8.3.3 UAE Real World Evidence Solutions Market by End-user
  • 8.3.4 UAE Real World Evidence Solutions Market by Application
• 8.4 Saudi Arabia Real World Evidence Solutions Market
  • 8.4.1 Saudi Arabia Real World Evidence Solutions Market by Component
  • 8.4.2 Saudi Arabia Real World Evidence Solutions Market by Therapeutic Area
  • 8.4.3 Saudi Arabia Real World Evidence Solutions Market by End-user
  • 8.4.4 Saudi Arabia Real World Evidence Solutions Market by Application
• 8.5 South Africa Real World Evidence Solutions Market
  • 8.5.1 South Africa Real World Evidence Solutions Market by Component
  • 8.5.2 South Africa Real World Evidence Solutions Market by Therapeutic Area
  • 8.5.3 South Africa Real World Evidence Solutions Market by End-user
  • 8.5.4 South Africa Real World Evidence Solutions Market by Application
• 8.6 Nigeria Real World Evidence Solutions Market
  • 8.6.1 Nigeria Real World Evidence Solutions Market by Component
  • 8.6.2 Nigeria Real World Evidence Solutions Market by Therapeutic Area
  • 8.6.3 Nigeria Real World Evidence Solutions Market by End-user
  • 8.6.4 Nigeria Real World Evidence Solutions Market by Application
• 8.7 Rest of LAMEA Real World Evidence Solutions Market
  • 8.7.1 Rest of LAMEA Real World Evidence Solutions Market by Component
  • 8.7.2 Rest of LAMEA Real World Evidence Solutions Market by Therapeutic Area
  • 8.7.3 Rest of LAMEA Real World Evidence Solutions Market by End-user
  • 8.7.4 Rest of LAMEA Real World Evidence Solutions Market by Application

Chapter 9. Company Profiles

• 9.1 IBM Corporation
  • 9.1.1 Company Overview
  • 9.1.2 Financial Analysis
  • 9.1.3 Regional & Segmental Analysis
  • 9.1.4 Research & Development Expenses
  • 9.1.5 Recent strategies and developments:
    • 9.1.5.1 Acquisition and Mergers:
  • 9.1.6 SWOT Analysis
• 9.2 Oracle Corporation
  • 9.2.1 Company Overview
  • 9.2.2 Financial Analysis
  • 9.2.3 Segmental and Regional Analysis
  • 9.2.4 Research & Development Expense
  • 9.2.5 SWOT Analysis
• 9.3 PPD, Inc. (Thermo Fisher Scientific, Inc.)
  • 9.3.1 Company Overview
  • 9.3.2 Financial Analysis
  • 9.3.3 Segmental and Regional Analysis
  • 9.3.4 Research & Development Expense
  • 9.3.5 SWOT Analysis
• 9.4 UnitedHealth Group, Inc. (Optum, Inc.)
  • 9.4.1 Company Overview
  • 9.4.2 Financial Analysis
  • 9.4.3 Segmental Analysis
• 9.5 Syneos Health, Inc.
  • 9.5.1 Company Overview
  • 9.5.2 Financial Analysis
  • 9.5.3 Segmental and Regional Analysis
  • 9.5.4 Recent strategies and developments:
    • 9.5.4.1 Acquisition and Mergers:
• 9.6 IQVIA Holdings, Inc.
  • 9.6.1 Company Overview
  • 9.6.2 Financial Analysis
  • 9.6.3 Segmental and Regional Analysis
  • 9.6.4 Recent strategies and developments:
    • 9.6.4.1 Partnerships, Collaborations, and Agreements:
    • 9.6.4.2 Acquisition and Mergers:
• 9.7 Medpace Holdings, Inc.
  • 9.7.1 Company Overview
  • 9.7.2 Financial Analysis
• 9.8 ICON plc
  • 9.8.1 Company Overview
  • 9.8.2 Financial Analysis
  • 9.8.3 Regional Analysis
  • 9.8.4 Recent strategies and developments:
    • 9.8.4.1 Acquisition and Mergers:
• 9.9 PerkinElmer, Inc.
  • 9.9.1 Company Overview
  • 9.9.2 Financial Analysis
  • 9.9.3 Segmental and Regional Analysis
  • 9.9.4 Research & Development Expense
  • 9.9.5 Recent strategies and developments:
    • 9.9.5.1 Product Launches and Product Expansions:
• 9.10. Parexel International Corporation (Phoenix Parentco, Inc.)
  • 9.10.1 Company Overview
  • 9.10.2 Recent strategies and developments:
    • 9.10.2.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

• TABLE 1 LAMEA Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 2 LAMEA Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 3 LAMEA Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 4 LAMEA Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 5 LAMEA Services Market by Country, 2018 - 2021, USD Million
• TABLE 6 LAMEA Services Market by Country, 2022 - 2028, USD Million
• TABLE 7 LAMEA Data Set Market by Country, 2018 - 2021, USD Million
• TABLE 8 LAMEA Data Set Market by Country, 2022 - 2028, USD Million
• TABLE 9 LAMEA Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 10 LAMEA Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 11 LAMEA Oncology Market by Country, 2018 - 2021, USD Million
• TABLE 12 LAMEA Oncology Market by Country, 2022 - 2028, USD Million
• TABLE 13 LAMEA Cardiology Market by Country, 2018 - 2021, USD Million
• TABLE 14 LAMEA Cardiology Market by Country, 2022 - 2028, USD Million
• TABLE 15 LAMEA Neurology Market by Country, 2018 - 2021, USD Million
• TABLE 16 LAMEA Neurology Market by Country, 2022 - 2028, USD Million
• TABLE 17 LAMEA Diabetes Market by Country, 2018 - 2021, USD Million
• TABLE 18 LAMEA Diabetes Market by Country, 2022 - 2028, USD Million
• TABLE 19 LAMEA Respiratory Market by Country, 2018 - 2021, USD Million
• TABLE 20 LAMEA Respiratory Market by Country, 2022 - 2028, USD Million
• TABLE 21 LAMEA Others Market by Country, 2018 - 2021, USD Million
• TABLE 22 LAMEA Others Market by Country, 2022 - 2028, USD Million
• TABLE 23 LAMEA Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 24 LAMEA Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 25 LAMEA Healthcare Companies Market by Country, 2018 - 2021, USD Million
• TABLE 26 LAMEA Healthcare Companies Market by Country, 2022 - 2028, USD Million
• TABLE 27 LAMEA Healthcare Payers Market by Country, 2018 - 2021, USD Million
• TABLE 28 LAMEA Healthcare Payers Market by Country, 2022 - 2028, USD Million
• TABLE 29 LAMEA Healthcare Providers Market by Country, 2018 - 2021, USD Million
• TABLE 30 LAMEA Healthcare Providers Market by Country, 2022 - 2028, USD Million
• TABLE 31 LAMEA Others Market by Country, 2018 - 2021, USD Million
• TABLE 32 LAMEA Others Market by Country, 2022 - 2028, USD Million
• TABLE 33 LAMEA Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 34 LAMEA Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 35 LAMEA Drug Development & Approvals Market by Country, 2018 - 2021, USD Million
• TABLE 36 LAMEA Drug Development & Approvals Market by Country, 2022 - 2028, USD Million
• TABLE 37 LAMEA Medical Device Development & Approvals Market by Country, 2018 - 2021, USD Million
• TABLE 38 LAMEA Medical Device Development & Approvals Market by Country, 2022 - 2028, USD Million
• TABLE 39 LAMEA Reimbursement/Coverage & Regulatory Decision Making Market by Country, 2018 - 2021, USD Million
• TABLE 40 LAMEA Reimbursement/Coverage & Regulatory Decision Making Market by Country, 2022 - 2028, USD Million
• TABLE 41 LAMEA Post Market Safety & Adverse Events Monitoring Market by Country, 2018 - 2021, USD Million
• TABLE 42 LAMEA Post Market Safety & Adverse Events Monitoring Market by Country, 2022 - 2028, USD Million
• TABLE 43 LAMEA Real World Evidence Solutions Market by Country, 2018 - 2021, USD Million
• TABLE 44 LAMEA Real World Evidence Solutions Market by Country, 2022 - 2028, USD Million
• TABLE 45 Brazil Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 46 Brazil Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 47 Brazil Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 48 Brazil Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 49 Brazil Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 50 Brazil Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 51 Brazil Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 52 Brazil Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 53 Brazil Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 54 Brazil Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 55 Argentina Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 56 Argentina Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 57 Argentina Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 58 Argentina Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 59 Argentina Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 60 Argentina Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 61 Argentina Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 62 Argentina Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 63 Argentina Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 64 Argentina Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 65 UAE Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 66 UAE Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 67 UAE Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 68 UAE Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 69 UAE Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 70 UAE Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 71 UAE Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 72 UAE Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 73 UAE Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 74 UAE Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 75 Saudi Arabia Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 76 Saudi Arabia Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 77 Saudi Arabia Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 78 Saudi Arabia Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 79 Saudi Arabia Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 80 Saudi Arabia Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 81 Saudi Arabia Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 82 Saudi Arabia Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 83 Saudi Arabia Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 84 Saudi Arabia Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 85 South Africa Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 86 South Africa Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 87 South Africa Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 88 South Africa Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 89 South Africa Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 90 South Africa Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 91 South Africa Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 92 South Africa Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 93 South Africa Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 94 South Africa Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 95 Nigeria Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 96 Nigeria Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 97 Nigeria Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 98 Nigeria Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 99 Nigeria Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 100 Nigeria Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 101 Nigeria Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 102 Nigeria Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 103 Nigeria Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 104 Nigeria Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 105 Rest of LAMEA Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 106 Rest of LAMEA Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 107 Rest of LAMEA Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 108 Rest of LAMEA Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 109 Rest of LAMEA Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 110 Rest of LAMEA Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 111 Rest of LAMEA Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 112 Rest of LAMEA Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 113 Rest of LAMEA Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 114 Rest of LAMEA Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 115 Key information - IBM Corporation
• TABLE 116 Key Information - Oracle Corporation
• TABLE 117 Key Information - PPD, Inc.
• TABLE 118 Key Information - UnitedHealth Group, Inc.
• TABLE 119 Key Information - Syneos Health, Inc.
• TABLE 120 Key information - IQVIA Holdings, Inc.
• TABLE 121 key Information - Medpace Holdings, Inc.
• TABLE 122 key Information - PerkinElmer, Inc.
• TABLE 123 Key Information - PAREXEL International Corporation

List of Figures

• FIG 1 Methodology for the research
• FIG 2 Swot analysis: IBM Corporation
• FIG 3 SWOT analysis: Oracle Corporation
• FIG 4 Swot analysis: thermo fisher scientific, inc.